A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

478

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Systemic Inflammatory MarkersPortal Vein Thrombosis
Interventions
DIAGNOSTIC_TEST

clinical laboratory tests, and imaging characteristics

Data included the demographic status, etiology of the liver disease, clinical laboratory tests, and imaging characteristics. Clinical laboratory tests included D-dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), antithrombin III, international normalized ratio (INR), thrombin time (TT), albumin (Alb), serum creatinine, hemoglobin, platelet count, white blood cell count, neutrophil count, lymphocyte count, monocyte count, model for end-stage liver disease (MELD) score, and Child-Pugh score. Imaging characteristics included splenic vein diameter, splenic vein velocity, portal vein diameter, and portal vein velocity.

Trial Locations (1)

Unknown

the Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05541562 - A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis | Biotech Hunter | Biotech Hunter